首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于MELD评价解毒凉血法治疗慢性乙型重型肝炎的疗效
引用本文:吴云忠,王宪波,叶航,江宇泳,孙凤霞,王融冰.基于MELD评价解毒凉血法治疗慢性乙型重型肝炎的疗效[J].临床肝胆病杂志,2011,27(5):467-470.
作者姓名:吴云忠  王宪波  叶航  江宇泳  孙凤霞  王融冰
作者单位:首都医科大学附属北京地坛医院,北京,100015
基金项目:国家"十一五"科技重大专项,国家中医药管理局中医药科学技术研究专项
摘    要:目的 评价解毒凉血法对慢性乙型重型肝炎患者的治疗作用;在中医辩证基础上,应用终末期肝病模型(MELD)评

关 键 词:肝炎,乙型,慢性  凉血解毒  终末期肝病模型

The effecacy of Jieduliangxuefa for the patients with chronic severe hepatitis B: using model for end-stage liver diseases(MELD)
WU Yun-zhong,WANG Xian-bo,YE Hang,et al..The effecacy of Jieduliangxuefa for the patients with chronic severe hepatitis B: using model for end-stage liver diseases(MELD)[J].Chinese Journal of Clinical Hepatology,2011,27(5):467-470.
Authors:WU Yun-zhong  WANG Xian-bo  YE Hang  
Institution:WU Yun-zhong,WANG Xian-bo,YE Hang,et al.(Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China)
Abstract:Objective To study the effect of Jieduliangxuefa in patients with chronic severe hepatitis B and to determine the opinion of the treatment crowd by using model for end-stage liver disease(MELD) scoring system.Methods 374 patients were randomly divided into Jieduliangxuefa group and control group,both the groups were treated with comprehensive physical treatment and MELD score was calculated according to the original formula for each patient.The efficacy of Jieduliangxuefa was assessed by mortality and impro...
Keywords:hepatitis B  chronic  COOLING BLOOD REMOV TOX MATER  model for end-stage liver disease  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号